Literature DB >> 27722165

Organ Transplantation in the Face of Donor Shortage - Ethical Implications with a Focus on Liver Allocation.

Michael Lauerer1, Katharina Kaiser1, Eckhard Nagel1.   

Abstract

BACKGROUND: Transplantation medicine is associated with several ethical issues related to the lack of organs. Major questions concern the regulations for giving permission for organ removal, informing the public about organ donation, setting of organ allocation priorities, waiting list access, and strategies to counteract scarcity.
METHODS: This contribution is based on analyses of legal regulations, guidelines of self-regulatory bodies, administrative data, and literature from medical, normative, and empiric disciplines. It addresses the above-mentioned issues descriptively with a focus on Germany and liver transplantation.
RESULTS: The basic principle of beneficence justifies a shift from voluntariness towards an obligation to document one's decision regarding organ donation. Organ allocation is obviously tangent to fundamental values and concepts of justice. At that, there is no consistent agreement on whether to prioritize the sickest patient or to maximize the overall health benefit. Restrictions relating to waiting list access are the subject of controversies. The reasons for denial of access are largely related to high demands on the prospect of success. Strategies to counteract organ scarcity partly conflict with the respect for autonomy, non-maleficence, beneficence, or justice.
CONCLUSION: We propose to focus on recent most promising strategies to counteract scarcity in the short-term: demanding a documented decision on organ donation and an orientation towards the Spanish model of organization. Concepts for waiting list access should constantly be reviewed considering all medical evidence and must not be based on moralism. Moreover, we suggest to consider public preferences for organ allocation and strengthen the confidence in transplantation medicine.

Entities:  

Keywords:  Organ allocation; Priority setting; Transplantation medicine

Year:  2016        PMID: 27722165      PMCID: PMC5040945          DOI: 10.1159/000446382

Source DB:  PubMed          Journal:  Visc Med        ISSN: 2297-4725


  25 in total

1.  Early liver transplantation for severe alcoholic hepatitis.

Authors:  Philippe Mathurin; Christophe Moreno; Didier Samuel; Jérôme Dumortier; Julia Salleron; François Durand; Hélène Castel; Alain Duhamel; Georges-Philippe Pageaux; Vincent Leroy; Sébastien Dharancy; Alexandre Louvet; Emmanuel Boleslawski; Valerio Lucidi; Thierry Gustot; Claire Francoz; Christian Letoublon; Denis Castaing; Jacques Belghiti; Vincent Donckier; François-René Pruvot; Jean-Charles Duclos-Vallée
Journal:  N Engl J Med       Date:  2011-11-10       Impact factor: 91.245

2.  Liver organ allocation for hepatocellular carcinoma: are we sure?

Authors:  J Wallis Marsh; Igor Dvorchik
Journal:  Liver Transpl       Date:  2003-07       Impact factor: 5.799

3.  [The Trade-Off between Chance of Success and Urgency in Organ Allocation: A Discrete Choice Experiment to Elicit Public Preferences].

Authors:  M Dao Van; M Lauerer; V Schätzlein; E Nagel
Journal:  Gesundheitswesen       Date:  2016-07-20

4.  Consensus conference: Indications for Liver Transplantation, January 19 and 20, 2005, Lyon-Palais Des Congrès: text of recommendations (long version).

Authors: 
Journal:  Liver Transpl       Date:  2006-06       Impact factor: 5.799

5.  Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany--limitations of the 'sickest first'-concept.

Authors:  Tobias J Weismüller; Panagiotis Fikatas; Jan Schmidt; Ana P Barreiros; Gerd Otto; Susanne Beckebaum; Andreas Paul; Markus N Scherer; Hartmut H Schmidt; Hans J Schlitt; Peter Neuhaus; Jürgen Klempnauer; Johann Pratschke; Michael P Manns; Christian P Strassburg
Journal:  Transpl Int       Date:  2010-09-03       Impact factor: 3.782

6.  Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival.

Authors:  F Y Yao; L Ferrell; N M Bass; J J Watson; P Bacchetti; A Venook; N L Ascher; J P Roberts
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

7.  Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters.

Authors:  Sasan Roayaie; Jason S Frischer; Sukru H Emre; Thomas M Fishbein; Patricia A Sheiner; Max Sung; Charles M Miller; Myron E Schwartz
Journal:  Ann Surg       Date:  2002-04       Impact factor: 12.969

Review 8.  Ethical considerations regarding early liver transplantation in patients with severe alcoholic hepatitis not responding to medical therapy.

Authors:  Vincent Donckier; Valerio Lucidi; Thierry Gustot; Christophe Moreno
Journal:  J Hepatol       Date:  2013-11-26       Impact factor: 25.083

9.  [Fairness judgements on the allocation of organ donations. Results of a factorial survey].

Authors:  C Gross; P Kriwy
Journal:  Gesundheitswesen       Date:  2008-09-10

10.  A shorter duration of pre-transplant abstinence predicts problem drinking after liver transplantation.

Authors:  Puneeta Tandon; Karen J Goodman; Mang M Ma; Winnie W Wong; Andrew L Mason; Glenda Meeberg; Donna Bergsten; Michelle Carbonneau; Vincent G Bain
Journal:  Am J Gastroenterol       Date:  2009-05-26       Impact factor: 10.864

View more
  4 in total

1.  Challenges in Liver Transplantation.

Authors:  Guido Gerken; Andreas Paul
Journal:  Visc Med       Date:  2016-08-15

2.  Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma.

Authors:  Arno Kornberg; Martina Schernhammer; Jennifer Kornberg; Helmut Friess; Katharina Thrum
Journal:  Dig Dis Sci       Date:  2018-09-27       Impact factor: 3.199

3.  Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma.

Authors:  Bas Groot Koerkamp; Stefan Buettner; Jaynee J A Vugts; Marcia P Gaspersz; Eva Roos; Lotte C Franken; Pim B Olthof; Robert J S Coelen; Jeroen L A van Vugt; Tim A Labeur; Lieke Brouwer; Marc G H Besselink; Jan N M IJzermans; Sarwa Darwish Murad; Thomas M van Gulik; Jeroen de Jonge; Wojciech G Polak; Olivier R C Busch; Joris L Erdmann
Journal:  Ann Surg Oncol       Date:  2020-09-08       Impact factor: 5.344

4.  Prognostic factors and scoring systems associated with outcome in pediatric acute liver failure.

Authors:  Priya Walabh; Anja Meyer; Tim de Maayer; Porai N Moshesh; Ibrahim E Hassan; Pravina Walabh; Christina Hajinicolaou
Journal:  BMC Pediatr       Date:  2022-08-31       Impact factor: 2.567

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.